2022 CCDS Symposium Session 5: 'Gene Therapy Approaches for CCDS'

preview_player
Показать описание
Gabriella Fernandes-Pires - Lausanne University Hospital
"AAV strategy to treat creatine transporter deficiency in the Slc6a8Y389C/y KI rat"

Laura Baroncelli - Neuroscience Institute CNR
"Creatine transporter deficiency: The long journey to successful therapy"

Gerald Lipshutz - UCLA
"AAV-based gene therapy restores cerebral creatine, reduces guanidinoacetate, and resolves of behavioral abnormalities in a mouse model of GAMT deficiency"

Q&A Panel with Lara Duran-Trio, Gabriella Fernandes-Pires, Laura Baroncelli, and Gerald Lipshutz (Moderator: Andreas Schulze)

#Creatinedeficiencies #CCDS #Creatineinfo #CCDS2022
Рекомендации по теме